Tuesday 20 October 2020
Home      All news      Contact us      RSS     
healtheuropa - 1 month ago

Study shows metyrapone effective for treating rare Cushing’s Syndrome

The first ever prospective study to test the safety and efficacy of metyrapone in patients with Cushing’s Syndrome in a real-life setting has shown successful results. HRA Pharma Rare Diseases has presented data from PROMPT, the first ever prospective study designed to confirm metyrapone efficacy and good tolerance in patients with endogenous Cushing’s Syndrome, with [ ] The post Study shows metyrapone effective for treating rare Cushing’s Syndrome appeared first on Health Europa.


Latest News
Hashtags:   

Study

 | 

shows

 | 

metyrapone

 | 

effective

 | 

treating

 | 

Cushing

 | 

Syndrome

 | 

Sources